Gallagher Carol Giltner
SEC-identified person · CIK 1329959 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| PMV Pharmaceuticals, Inc. PMVP | Director | filed 2022 - 2026 |
| Atara Biotherapeutics, Inc. ATRA | Director | filed 2014 - 2025 |
| Mirati Therapeutics, Inc. mrtx | Director | filed 2023 - 2024 |
| Frazier Lifesciences Acquisition Corp FLAC | Director | filed 2020 - 2022 |
| Turning Point Therapeutics, Inc. TPTX | Director | filed 2019 - 2022 |
| Certara, Inc. CERT | Director | filed 2021 - 2021 |
| Metacrine, Inc. MTCR | Director | filed 2020 - 2020 |
| Annexon, Inc. ANNX | Director | filed 2020 - 2020 |
| Tempest Therapeutics, Inc. TPST | Director | filed 2018 - 2020 |
| Anaptysbio, INC ANAB | Director | filed 2017 - 2018 |
| Anadys Pharmaceuticals INC ANDS | VP, Corp. Dev. & Comm. Affairs | filed 2007 - 2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.